Amgen’s cancer sales to grow in 2012, CEO-to-be reports

SAN FRANCISCO - Amgen Inc.,the world’s largest biotechnology company with a facility in West Greenwich, will see revenue accelerate this year as sales of its cancer medicines grow and win wider regulatory approval, the next CEO said. Robert Bradway, the company’s president and chief operating officer, will replace CEO Kevin Sharer, who is retiring, in…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -